-
North Korea acknowledges its troops cleared mines for Russia
-
US unseals warrant for tanker seized off Venezuelan coast
-
Cambodia says Thailand still bombing hours after Trump truce call
-
Machado urges pressure so Maduro understands 'he has to go'
-
Leinster stutter before beating Leicester in Champions Cup
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
-
Union sink second-placed Leipzig to climb in Bundesliga
-
US Treasury lifts sanctions on Brazil Supreme Court justice
-
UK king shares 'good news' that cancer treatment will be reduced in 2026
-
Wembanyama expected to return for Spurs in NBA Cup clash with Thunder
-
Five takeaways from Luigi Mangione evidence hearings
-
UK's king shares 'good news' that cancer treatment will be reduced in 2026
-
Steelers' Watt undergoes surgery to repair collapsed lung
-
Iran detains Nobel-prize winner in 'brutal' arrest
-
NBA Cup goes from 'outside the box' idea to smash hit
-
UK health service battles 'super flu' outbreak
-
Can Venezuela survive US targeting its oil tankers?
-
Democrats release new cache of Epstein photos
-
Colombia's ELN guerrillas place communities in lockdown citing Trump 'intervention' threats
-
'Don't use them': Tanning beds triple skin cancer risk, study finds
-
Nancy aims to restore Celtic faith with Scottish League Cup final win
-
Argentina fly-half Albornoz signs for Toulon until 2030
-
Trump says Thailand, Cambodia have agreed to stop border clashes
-
Salah in Liverpool squad for Brighton after Slot talks - reports
-
Marseille coach tips Greenwood as 'potential Ballon d'Or'
-
Draw marks 'starting gun' toward 2026 World Cup, Vancouver says
-
Thai PM says asked Trump to press Cambodia on border truce
-
Salah admired from afar in his Egypt home village as club tensions swirl
-
World stocks retrench, consolidating Fed-fuelled gains
-
Brazil left calls protests over bid to cut Bolsonaro jail time
-
Trump attack on Europe migration 'disaster' masks toughening policies
-
US plan sees Ukraine joining EU in 2027, official tells AFP
-
'Chilling effect': Israel reforms raise press freedom fears
-
Iran frees child bride sentenced to death over husband's killing: activists
-
No doubting Man City boss Guardiola's passion says Toure
-
Youthful La Rochelle name teen captain for Champions Cup match in South Africa
-
World stocks consolidate Fed-fuelled gains
-
British 'Aga saga' author Joanna Trollope dies aged 82
-
Man Utd sweat on Africa Cup of Nations trio
-
EU agrees three-euro small parcel tax to tackle China flood
-
Taylor Swift breaks down in Eras documentary over Southport attack
-
Maresca 'relaxed' about Chelsea's rough patch
-
France updates net-zero plan, with fossil fuel phaseout
-
Nowhere to pray as logs choke flood-hit Indonesian mosque
-
In Pakistan, 'Eternal Love' has no place on YouTube
-
England bowling great Anderson named as Lancashire captain
-
UK's King Charles to give personal TV message about cancer 'journey'
-
Fit-again Jesus can be Arsenal's number one striker, says Arteta
-
Spain's ruling Socialists face sex scandal fallout among women voters
Wellgistics Health Converts $8.1M Debt to Equity
TAMPA, FLORIDA / ACCESS Newswire / July 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that its Board of Directors has approved an $8.1 million debt-to-equity conversion.
Led by CEO Brian Norton and former minority partners of Wellgistics, LLC, which was acquired by Wellgistics Health in 2024, the transaction strengthens the Company's balance sheet by materially reducing the Company's short-term debt.
The transaction is also expected to:
Accelerate the Company's cash flow by unlocking more favorable terms and capital access;
Improve Wellgistics Health's ability to acquire high-demand pharmaceutical products at competitive prices;
Expand the Company's national footprint by growing its network of independent pharmacies; and
Strengthen the Company's proprietary technology platform, including AI-powered hub services and digital prescription routing
"This conversion will make a significant contribution in enabling us to accelerate our business plan and accomplish the goals we believe will help transform the prescription drug marketplace and drive long-term value for our shareholders," said Wellgistics Health CFO Mark DiSiena.
"We look forward to sharing additional positive developments in the near future."
About Wellgistics Health
Wellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, offering wholesale distribution, digital script routing, and AI-driven hub services like eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health delivers seamless, compliant, end-to-end solutions designed to restore access, transparency, and trust in U.S. healthcare.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
Media Contact: [email protected]
Investor Relations: [email protected]
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: [email protected]
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
W.Morales--AT